NK
NKGen Biotech, Inc. Warrants
NKGNW · NASDAQ
$0.03 +2,408.33% (+$0.03)
Market Cap $6.18M
P/E Ratio -
Div. Yield -
ROE 103.10%
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 9.48x
EV/FFO N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 6,792.33%
Op. margin 4,135.89%
FCF margin 3,202.61%
Quality
75 /100
Excellent ROA 184,525.00%
Asset turnover 27.17x
ROE 103.10%
Debt
64 /100
Moderate Net debt/EBITDA 0.00x
Int. coverage 0.00x
Current ratio N/A
Stability
37 /100
Moderate EPS volatility 211.35%
Profitable years 0
Beta 0.64x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NKGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Y. Song
Employees
63
Headquarters
Santa Ana